
Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group
Yeo, W., Chung, H. C., Chan, S. L., Wang, L. Z., Lim, R., Picus, J., Boyer, M., Mo, F. K. F., Koh, J., Rha, S. Y., Hui, E. P., Jeung, H. C., Roh, J. K., Yu, S. C. H., To, K. F., Tao, Q., Ma, B. B., ChVolume:
30
Langue:
english
Pages:
7
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2011.41.2395
Date:
September, 2012
Fichier:
PDF, 1.84 MB
english, 2012